Загрузка...
Intracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19
OBJECTIVES: Intracerebral hemorrhage/bleeding (ICH) after an infection with SARS-CoV-2 (COVID-19) treated with the Janus-kinase inhibitor baricitinib has not been reported. CASE PRESENTATION: A 86yo Caucasian female suddenly developed aphasia with a systolic blood pressure of 220 mmHg. Cerebral imag...
Сохранить в:
| Опубликовано в: : | Brain Hemorrhages |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8256660/ https://ncbi.nlm.nih.gov/pubmed/34250455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hest.2021.06.005 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|